FDA Inspection
Atlanta Blood ServicesAtlanta Blood Services – FDA Inspection, Nov 3, 2008
Record Details
This FDA Inspection record concerns Atlanta Blood Services, with an inspection on November 3, 2008, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Atlanta Blood Services
- Inspection Date
- November 3, 2008
- Product Type
- Biologics
View Company Profile
ID · 35cd3b48-0cd3-4e92-b9e6-90c5d28299c8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 549353
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Atlanta Blood Services
7| Date | Classification | Office | Project area |
|---|---|---|---|
| June 4, 2026 | Not classified | Atlanta District Office | |
| November 11, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| February 6, 2019 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| October 15, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 28, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Atlanta Blood Services
- FDA Inspection 1324986 - 2026-06-04
- FDA Inspection 1193134 - 2022-11-11
- FDA Inspection 1079952 - 2019-02-06
- FDA Inspection 946036 - 2015-10-15
- FDA Inspection 820185 - 2013-02-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.